Motor neuron disease: a chemical perspective
Laura K Wood1, Steven J Langford
1School of Chemistry, Monash University , Clayton, Victoria 3800, Australia.
Journal of Medicinal Chemistry
|April 4, 2014
Abstract:
This Perspective provides a background to the pathogenesis of neurodegenerative disease and specifically amyotrophic lateral sclerosis (ALS) and gives an overview of the many pathways, both genetically inheritable and sporadic, that may lead to the premature activation of apoptotic pathways in neurons, as well as current and proposed approaches toward interrupting these pathways.
Insights
This perspective explores the causes of neurodegenerative diseases, focusing on amyotrophic lateral sclerosis (ALS). It details pathways leading to neuron death and discusses strategies to halt these processes.
Area of Science:
- Neuroscience
- Cell Biology
- Pathogenesis
Background:
- Neurodegenerative diseases involve neuron dysfunction and death.
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder.
- Apoptotic pathways play a critical role in neuron loss.
Purpose of the Study:
- To provide a background on neurodegenerative disease pathogenesis.
- To specifically detail the pathogenesis of amyotrophic lateral sclerosis (ALS).
- To overview pathways leading to premature neuronal apoptosis and discuss intervention strategies.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of genetic and sporadic pathways in neurodegeneration.
- Review of current and proposed therapeutic approaches.
Main Results:
- Identified multiple genetic and sporadic pathways contributing to neurodegeneration.
- Highlighted the role of premature apoptotic pathway activation in neurons.
- Summarized diverse therapeutic strategies targeting neuronal apoptosis.
Conclusions:
- Understanding disease pathways is crucial for developing effective treatments.
- Targeting apoptotic pathways offers potential therapeutic avenues for ALS.
- Further research is needed to translate these approaches into clinical practice.
More Related Videos
Related Concept Videos
01:26Chemical Synapses
10.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K
01:26Chemical Synapses
9.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.5K
01:29Neuromuscular Junction And Blockade
5.9K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.9K
01:22Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
01:19The Neuromuscular Junction
17.6K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
17.6K
01:26Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K